Annual CAPEX:
$74.99M+$5.80M(+8.38%)Summary
- As of today, AMRX annual capital expenditures is $74.99 million, with the most recent change of +$5.80 million (+8.38%) on December 31, 2024.
- During the last 3 years, AMRX annual CAPEX has risen by +$25.56 million (+51.72%).
- AMRX annual CAPEX is now -56.31% below its all-time high of $171.66 million, reached on December 1, 2012.
Performance
AMRX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CAPEX:
$27.40M+$9.08M(+49.56%)Summary
- As of today, AMRX quarterly capital expenditures is $27.40 million, with the most recent change of +$9.08 million (+49.56%) on June 30, 2025.
- Over the past year, AMRX quarterly CAPEX has increased by +$15.95 million (+139.24%).
- AMRX quarterly CAPEX is now -69.43% below its all-time high of $89.65 million, reached on September 1, 2012.
Performance
AMRX Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$89.50M+$15.95M(+21.68%)Summary
- As of today, AMRX TTM capital expenditures is $89.50 million, with the most recent change of +$15.95 million (+21.68%) on June 30, 2025.
- Over the past year, AMRX TTM CAPEX has increased by +$13.12 million (+17.17%).
- AMRX TTM CAPEX is now -50.75% below its all-time high of $181.71 million, reached on September 1, 2012.
Performance
AMRX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
AMRX CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +8.4% | +139.2% | +17.2% |
| 3Y3 Years | +51.7% | +82.1% | +62.2% |
| 5Y5 Years | -23.0% | +220.4% | +156.2% |
AMRX CAPEX Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -17.2% | +51.7% | -46.2% | +139.2% | -6.2% | +82.8% |
| 5Y | 5-Year | -23.0% | +51.7% | -46.2% | +229.8% | -6.2% | +156.2% |
| All-Time | All-Time | -56.3% | >+9999.0% | -69.4% | >+9999.0% | -50.8% | >+9999.0% |
AMRX CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $27.40M(+49.6%) | $89.50M(+21.7%) |
| Mar 2025 | - | $18.32M(-20.6%) | $73.55M(-1.9%) |
| Dec 2024 | $74.99M(+8.4%) | $23.06M(+11.4%) | $74.99M(-10.3%) |
| Sep 2024 | - | $20.71M(+80.8%) | $83.62M(+9.5%) |
| Jun 2024 | - | $11.45M(-42.0%) | $76.38M(-1.1%) |
| Mar 2024 | - | $19.76M(-37.6%) | $77.21M(+11.6%) |
| Dec 2023 | $69.19M(-23.6%) | $31.69M(+135.2%) | $69.19M(+41.3%) |
| Sep 2023 | - | $13.48M(+9.7%) | $48.96M(-43.3%) |
| Jun 2023 | - | $12.28M(+4.7%) | $86.39M(-3.1%) |
| Mar 2023 | - | $11.74M(+2.4%) | $89.15M(+1.1%) |
| Dec 2022 | $90.59M(+83.3%) | $11.47M(-77.5%) | $88.21M(-7.6%) |
| Sep 2022 | - | $50.90M(+238.2%) | $95.44M(+72.9%) |
| Jun 2022 | - | $15.05M(+39.4%) | $55.19M(+13.9%) |
| Mar 2022 | - | $10.79M(-42.3%) | $48.45M(-2.0%) |
| Dec 2021 | $49.43M(-18.7%) | $18.70M(+75.7%) | $49.43M(-19.4%) |
| Sep 2021 | - | $10.64M(+28.1%) | $61.36M(-4.0%) |
| Jun 2021 | - | $8.31M(-29.4%) | $63.91M(-0.4%) |
| Mar 2021 | - | $11.78M(-61.6%) | $64.15M(+5.5%) |
| Dec 2020 | $60.80M(-37.6%) | $30.63M(+132.2%) | $60.80M(+74.1%) |
| Sep 2020 | - | $13.19M(+54.3%) | $34.93M(+0.5%) |
| Jun 2020 | - | $8.55M(+1.6%) | $34.77M(-60.4%) |
| Mar 2020 | - | $8.42M(+76.6%) | $87.86M(-9.8%) |
| Dec 2019 | $97.43M(+0.4%) | $4.77M(-63.4%) | $97.43M(-13.5%) |
| Sep 2019 | - | $13.04M(-78.9%) | $112.69M(-17.8%) |
| Jun 2019 | - | $61.64M(+242.7%) | $137.12M(+43.5%) |
| Mar 2019 | - | $17.99M(-10.2%) | $95.58M(-1.6%) |
| Dec 2018 | $97.09M(-15.0%) | $20.02M(-46.6%) | $97.09M(-4.5%) |
| Sep 2018 | - | $37.47M(+86.4%) | $101.68M(+2.4%) |
| Jun 2018 | - | $20.10M(+3.1%) | $99.26M(+25.4%) |
| Mar 2018 | - | $19.50M(-20.8%) | $79.16M(+32.7%) |
| Dec 2017 | $114.27M(+116.0%) | $24.62M(-29.7%) | $59.66M(+13.5%) |
| Sep 2017 | - | $35.04M(+99.8%) | $52.58M(-0.6%) |
| Dec 2016 | $52.90M(+70.4%) | - | - |
| Dec 2016 | - | $17.54M(+54.6%) | $52.90M(+14.6%) |
| Sep 2016 | - | $11.35M(+17.8%) | $46.15M(+12.5%) |
| Jun 2016 | - | $9.63M(-33.0%) | $41.03M(-0.4%) |
| Mar 2016 | - | $14.38M(+33.3%) | $41.21M(+32.7%) |
| Dec 2015 | $31.05M(-27.6%) | $10.79M(+73.3%) | $31.05M(+10.1%) |
| Sep 2015 | - | $6.23M(-36.5%) | $28.20M(-20.9%) |
| Jun 2015 | - | $9.81M(+132.3%) | $35.67M(+0.9%) |
| Mar 2015 | - | $4.22M(-46.8%) | $35.35M(-17.6%) |
| Dec 2014 | $42.91M(-4.2%) | $7.95M(-42.0%) | $42.91M(-22.7%) |
| Sep 2014 | - | $13.70M(+44.3%) | $55.53M(+20.8%) |
| Jun 2014 | - | $9.49M(-19.5%) | $45.98M(-2.6%) |
| Mar 2014 | - | $11.78M(-42.7%) | $47.21M(+5.4%) |
| Dec 2013 | $44.78M | $20.56M(+395.9%) | $44.78M(+70.5%) |
| Sep 2013 | - | $4.15M(-61.3%) | $26.26M(-76.5%) |
| Jun 2013 | - | $10.71M(+14.5%) | $111.76M(-24.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2013 | - | $9.36M(+358.4%) | $147.86M(-13.9%) |
| Dec 2012 | $171.66M(+462.4%) | $2.04M(-97.7%) | $171.66M(-5.5%) |
| Sep 2012 | - | $89.65M(+91.5%) | $181.71M(+89.4%) |
| Jun 2012 | - | $46.81M(+41.1%) | $95.93M(+74.5%) |
| Mar 2012 | - | $33.16M(+174.3%) | $54.97M(+80.1%) |
| Dec 2011 | $30.52M(+87.6%) | $12.09M(+212.9%) | $30.52M(+26.3%) |
| Sep 2011 | - | $3.86M(-33.9%) | $24.16M(+4.4%) |
| Jun 2011 | - | $5.85M(-33.0%) | $23.15M(+5.8%) |
| Mar 2011 | - | $8.72M(+52.3%) | $21.87M(+34.5%) |
| Dec 2010 | $16.27M(+12.8%) | $5.73M(+100.8%) | $16.27M(+2.9%) |
| Sep 2010 | - | $2.85M(-37.7%) | $15.80M(-1.2%) |
| Jun 2010 | - | $4.57M(+46.8%) | $15.99M(+23.9%) |
| Mar 2010 | - | $3.12M(-40.8%) | $12.90M(-5.6%) |
| Dec 2009 | $14.42M(-44.3%) | $5.26M(+73.2%) | $13.67M(+2.0%) |
| Sep 2009 | - | $3.04M(+104.4%) | $13.39M(-27.4%) |
| Jun 2009 | - | $1.49M(-61.7%) | $18.45M(+8.8%) |
| Mar 2009 | - | $3.88M(-22.2%) | $16.97M(+29.7%) |
| Dec 2008 | $25.86M(+37.3%) | $4.99M(-38.4%) | $13.09M(+61.6%) |
| Sep 2008 | - | $8.10M(+234.2%) | $8.10M(-19.3%) |
| Dec 2007 | $18.84M(-12.3%) | - | - |
| Dec 2006 | $21.48M(+45.5%) | - | - |
| Dec 2005 | $14.76M(+235.4%) | - | - |
| Sep 2004 | - | $2.42M(-42.9%) | $10.03M(+5.1%) |
| Jun 2004 | - | $4.24M(+109.6%) | $9.55M(+66.6%) |
| Mar 2004 | - | $2.02M(+51.2%) | $5.73M(+30.1%) |
| Dec 2003 | $4.40M(-70.8%) | $1.34M(-30.9%) | $4.40M(-19.4%) |
| Sep 2003 | - | $1.94M(+353.9%) | $5.46M(-41.9%) |
| Jun 2003 | - | $427.00K(-38.8%) | $9.41M(-7.3%) |
| Mar 2003 | - | $698.00K(-70.9%) | $10.15M(-32.6%) |
| Dec 2002 | $15.05M(-9.2%) | $2.40M(-59.2%) | $15.05M(-30.2%) |
| Sep 2002 | - | $5.88M(+403.9%) | $21.56M(+13.1%) |
| Jun 2002 | - | $1.17M(-79.1%) | $19.06M(-13.8%) |
| Mar 2002 | - | $5.60M(-37.1%) | $22.10M(+33.3%) |
| Dec 2001 | $16.57M(+365.2%) | $8.90M(+162.9%) | $16.57M(+96.5%) |
| Sep 2001 | - | $3.39M(-19.5%) | $8.44M(+48.9%) |
| Jun 2001 | - | $4.21M(+5293.6%) | $5.66M(+65.9%) |
| Mar 2001 | - | $78.00K(-89.8%) | $3.42M(-4.2%) |
| Dec 2000 | $3.56M(+679.6%) | $764.00K(+24.2%) | $3.56M(+14.6%) |
| Sep 2000 | - | $615.00K(-68.6%) | $3.11M(+21.8%) |
| Jun 2000 | - | $1.96M(+766.4%) | $2.55M(+280.9%) |
| Mar 2000 | - | $226.00K(-26.9%) | $670.00K(+46.6%) |
| Dec 1999 | $457.00K(+1.6%) | $309.00K(+423.7%) | $457.00K(+151.1%) |
| Sep 1999 | - | $59.00K(-22.4%) | $182.00K(+19.0%) |
| Jun 1999 | - | $76.00K(+484.6%) | $153.00K(+17.7%) |
| Mar 1999 | - | $13.00K(-61.8%) | $130.00K(-71.1%) |
| Dec 1998 | $450.00K | $34.00K(+13.3%) | $450.00K(+8.2%) |
| Sep 1998 | - | $30.00K(-43.4%) | $416.00K(+7.8%) |
| Jun 1998 | - | $53.00K(-84.1%) | $386.00K(+15.9%) |
| Mar 1998 | - | $333.00K | $333.00K |
FAQ
- What is Amneal Pharmaceuticals, Inc. annual capital expenditures?
- What is the all-time high annual CAPEX for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. annual CAPEX year-on-year change?
- What is Amneal Pharmaceuticals, Inc. quarterly capital expenditures?
- What is the all-time high quarterly CAPEX for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. quarterly CAPEX year-on-year change?
- What is Amneal Pharmaceuticals, Inc. TTM capital expenditures?
- What is the all-time high TTM CAPEX for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. TTM CAPEX year-on-year change?
What is Amneal Pharmaceuticals, Inc. annual capital expenditures?
The current annual CAPEX of AMRX is $74.99M
What is the all-time high annual CAPEX for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high annual capital expenditures is $171.66M
What is Amneal Pharmaceuticals, Inc. annual CAPEX year-on-year change?
Over the past year, AMRX annual capital expenditures has changed by +$5.80M (+8.38%)
What is Amneal Pharmaceuticals, Inc. quarterly capital expenditures?
The current quarterly CAPEX of AMRX is $27.40M
What is the all-time high quarterly CAPEX for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high quarterly capital expenditures is $89.65M
What is Amneal Pharmaceuticals, Inc. quarterly CAPEX year-on-year change?
Over the past year, AMRX quarterly capital expenditures has changed by +$15.95M (+139.24%)
What is Amneal Pharmaceuticals, Inc. TTM capital expenditures?
The current TTM CAPEX of AMRX is $89.50M
What is the all-time high TTM CAPEX for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high TTM capital expenditures is $181.71M
What is Amneal Pharmaceuticals, Inc. TTM CAPEX year-on-year change?
Over the past year, AMRX TTM capital expenditures has changed by +$13.12M (+17.17%)